155 related articles for article (PubMed ID: 15264869)
1. Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues.
Aronov O; Horowitz AT; Gabizon A; Fuertes MA; Pérez JM; Gibson D
Bioconjug Chem; 2004; 15(4):814-23. PubMed ID: 15264869
[TBL] [Abstract][Full Text] [Related]
2. Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies.
Aronov O; Horowitz AT; Gabizon A; Gibson D
Bioconjug Chem; 2003; 14(3):563-74. PubMed ID: 12757380
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides.
Moore NM; Sheppard CL; Sakiyama-Elbert SE
Acta Biomater; 2009 Mar; 5(3):854-64. PubMed ID: 18926782
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cellular uptake and cytotoxicity studies of organometallic bioconjugates of the NLS peptide in Hep G2 cells.
Noor F; Kinscherf R; Bonaterra GA; Walczak S; Wölfl S; Metzler-Nolte N
Chembiochem; 2009 Feb; 10(3):493-502. PubMed ID: 19115329
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of acridine-nuclear localization signal (NLS) conjugates and evaluation of their impact on lipoplex and polyplex-based transfection.
Boulanger C; Di Giorgio C; Vierling P
Eur J Med Chem; 2005 Dec; 40(12):1295-306. PubMed ID: 16225967
[TBL] [Abstract][Full Text] [Related]
6. Can nuclear localization signals enhance nuclear localization of plasmid DNA?
Nagasaki T; Myohoji T; Tachibana T; Futaki S; Tamagaki S
Bioconjug Chem; 2003; 14(2):282-6. PubMed ID: 12643737
[TBL] [Abstract][Full Text] [Related]
7. Nuclear localisation sequence templated nonviral gene delivery vectors: investigation of intracellular trafficking events of LMD and LD vector systems.
Keller M; Harbottle RP; Perouzel E; Colin M; Shah I; Rahim A; Vaysse L; Bergau A; Moritz S; Brahimi-Horn C; Coutelle C; Miller AD
Chembiochem; 2003 Apr; 4(4):286-98. PubMed ID: 12672108
[TBL] [Abstract][Full Text] [Related]
8. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
Singh P; Gupta U; Asthana A; Jain NK
Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
[TBL] [Abstract][Full Text] [Related]
9. Nuclear targeting of non-viral gene carriers using psoralen-nuclear localization signal (NLS) conjugates.
Yoo HS; Jeong SY
Eur J Pharm Biopharm; 2007 Apr; 66(1):28-33. PubMed ID: 17123797
[TBL] [Abstract][Full Text] [Related]
10. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
[TBL] [Abstract][Full Text] [Related]
11. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
[TBL] [Abstract][Full Text] [Related]
12. Optimization of nuclear localization signal for nuclear transport of DNA-encapsulating particles.
Eguchi A; Furusawa H; Yamamoto A; Akuta T; Hasegawa M; Okahata Y; Nakanishi M
J Control Release; 2005 Jun; 104(3):507-19. PubMed ID: 15911050
[TBL] [Abstract][Full Text] [Related]
13. Targeted delivery of plasmid DNA into the nucleus of cells via nuclear localization signal peptide conjugated to DNA intercalating bis- and trisacridines.
Shiraishi T; Hamzavi R; Nielsen PE
Bioconjug Chem; 2005; 16(5):1112-6. PubMed ID: 16173787
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry.
Hah SS; Stivers KM; de Vere White RW; Henderson PT
Chem Res Toxicol; 2006 May; 19(5):622-6. PubMed ID: 16696564
[TBL] [Abstract][Full Text] [Related]
16. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
[TBL] [Abstract][Full Text] [Related]
17. Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.
Salmaso S; Semenzato A; Caliceti P; Hoebeke J; Sonvico F; Dubernet C; Couvreur P
Bioconjug Chem; 2004; 15(5):997-1004. PubMed ID: 15366952
[TBL] [Abstract][Full Text] [Related]
18. pH-activated size reduction of large compound nanoparticles for in vivo nucleus-targeted drug delivery.
Fan Y; Li C; Li F; Chen D
Biomaterials; 2016 Apr; 85():30-9. PubMed ID: 26854389
[TBL] [Abstract][Full Text] [Related]
19. Adamantane-platinum conjugate hosted in β-cyclodextrin: enhancing transport and cytotoxicity by noncovalent modification.
Prashar D; Shi Y; Bandyopadhyay D; Dabrowiak JC; Luk YY
Bioorg Med Chem Lett; 2011 Dec; 21(24):7421-5. PubMed ID: 22050886
[TBL] [Abstract][Full Text] [Related]
20. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
